Introduction:
Cardiovascular disease is the most frequent cause of adult death worldwide. In many western countries the incidence of ischaemic heart disease (IHD) has been falling for the last two or three decades, but it is rising in eastern Europe and in Indian subcontinent, and this has led to predictions that cardiovascular disease will soon become the leading cause of death in all continents 1 . About 7.1 million deaths occurred globally in 1999 due to Coronary Heart Diseases and it will rise to 11.1 million by 2020. WHO predicted that coronary heart disease (CHD) will be the top of the contributors to disease burden by 2020 and world will have to face the challenge of the crippling complications of the disease. Now a day's percutaneous coronary intervention (PCI) is a commonly done procedure in the arena of interventional cardiology 2 . This has revolutionized the management of coronary artery disease. At present, the number of PCIs performed exceeds the number of coronary artery bypass graft (CABG) surgery almost everywhere 3, 4 .
There are several options for treatment of CHD like nonpharmacologic, pharmacolgic, PTCA and surgical procedures. With the combination of sophisticated equipment, experienced operators, and modern drug therapy, percutaneous coronary interventions has evolved into an effective non-surgical modality of treatment 5 . Elizabeth (2005) , demonstrated that patients with reduced Ejection Fraction (EF) have higher in-hospital mortality and other adverse outcome 6 .
Materials and Methods:
This study was carried out at the University Cardiac Centre, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, during the period between January 2006 to July 2006. A total consecutive 60 patients were divided into two groups. Group-I (n=32) included those patients having impaired left ventricular ejection fraction (LVEF) <50%, rest of the patients were included in group-II having preserved left ventricular ejection fraction (LVEF), ³50%. Patients with low EF undergoing PCI were the study population.
Inclusion criteria:
• Patients having prior MI with low ejection fractions undergoing PCI were taken as cases.
• Patients having low ejection fraction without prior MI were taken as control.
Exclusion criteria:
• Chronic renal failure (S. Creatinine level >2.5 mg/dl).
• Hepatic failure.
• Patients having valvular heart disease.
Methology:
• Informed written consent was taking from each patient.
• Detailed history was taken and thorough clinical examination were performed. • LVEF were confirmed by ventriculography.
• Patients categorized according to the base line LVEF level-Cases-LVEF <50%, Control-LVEF ³50%
• Preprocedural angiographic variables including number of stenosed vessel (single / double /triple), degree of stenosis (0-100%).
• Echocardiography was performed in all patients before discharge to see the improvement of LVEF after PCI.
Results:
A total of 60 patients of coronary artery disease were studied to assess the impact of ejection fraction on the outcome of PCI and the impact of PCI on EF. The results obtained from data analysis are presented below. Table I shows that out of total 60 patients 18(30%) were between the age of 40 -49 years and another 18(30%) were between 50 -59 years of age. About 22% were between 60 -70 years, 11.7% below 40 years and only 6.7% 50 years of age or above. The median age was found to be 50 ± 10.5 years and the lowest and highest ages being 32 and 75 years respectively. Fig. 2 shows the distribution of patients by LVEF. More than half (51.7%) of the patients had LVEF between 40 -49% followed by 33.3% had 60 or above 60%, 13.3% between 50 -59% and only 1(1.7%) patient had below 40%. Fig. 1 shows that out of total 60 patients 49 (82%) were male and the rest 11(18%) were female giving a male-female ratio of roughly 4.5:1. Fig: 3 shows mean LVEF before PCI in patient with prior MI was 45.08% and patient without prior MI was 54.75%. So, it may be concluded that, more attention should be paid to the ventricular ejection fraction of the patients before carrying out any coronary intervention. In patients having CAD, revascularization in the form of PCI should be performed as early as possible in patients having prior MI, revascularization should be performed after doing tests to detect viable myocardium. Randomized control trial should be conducted in future to determine the role of ejection fraction before PCI.
Fig. 1: Distribution of patients by sex

Fig. 4: Distribution of patients according to LVEF subgroups
Conclusion:
Ischaemic heart disease (IHD) is an alarming health problem. Patients with IHD gradually develop congestive heart failure and ischaemic cardiomyopathy due to either ignorance or negligence about treatment 7, 8 . Early revascularization not only prevent clinical deterioration but also improve LVEF 9, 10 . In late stage, revascularization has little clinical benefit even associated with more procedural complications. In patients having CAD, revascularization in the form of PCI should be performed as early as possible in patients having prior MI, revascularization should be performed after doing tests to detect viable myocardium. Randomized control trial should be conducted in future to determine the role of ejection fraction calculation in success of PCI .
